These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29103657)

  • 21. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.
    Glaser R; Selzer F; Jacobs AK; Laskey WK; Kelsey SF; Holper EM; Cohen HA; Abbott JD; Wilensky RL
    Am J Cardiol; 2006 Dec; 98(11):1446-50. PubMed ID: 17126647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
    Mizia-Stec K; Mizia M; Haberka M; Lasota B; Gieszczyk-Strózik K; Chmiel A; Najda J; Gąsior Z; Kyrcz-Krzemień S
    Cardiol J; 2013; 20(5):478-85. PubMed ID: 24469870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
    Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing the cost-effectiveness of percutaneous coronary intervention for chronic total occlusion in stable angina: a decision-analytic model.
    Gada H; Whitlow PL; Marwick TH
    Heart; 2012 Dec; 98(24):1790-7. PubMed ID: 23038791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina.
    Leibundgut G; Lee JH; Strauss BH; Segev A; Tsimikas S
    J Thromb Thrombolysis; 2016 May; 41(4):569-80. PubMed ID: 26964999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention.
    Takagi W; Miyoshi T; Doi M; Okawa K; Nosaka K; Nishibe T; Matsuo N; Hirohata S; Ito H
    BMC Cardiovasc Disord; 2017 Oct; 17(1):258. PubMed ID: 29017449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
    Mohee K; Wheatcroft SB
    J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A targeted approach to reducing overutilization: use of percutaneous coronary intervention in stable coronary artery disease.
    Behnke LM; Solis A; Shulman SA; Skoufalos A
    Popul Health Manag; 2013 Jun; 16(3):164-8. PubMed ID: 23113635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial.
    Xu DP; Wu HL; Lan TH; Wang X; Sheng XG; Lin Y; Li S; Zheng CY
    Chin J Integr Med; 2015 Jun; 21(6):408-16. PubMed ID: 26063318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials.
    D'Ascenzo F; Barbero U; Moretti C; Palmerini T; Della Riva D; Mariani A; Omedè P; DiNicolantonio JJ; Biondi-Zoccai G; Gaita F
    Contemp Clin Trials; 2014 May; 38(1):51-8. PubMed ID: 24657881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angina after percutaneous coronary intervention: The need for precision medicine.
    Niccoli G; Montone RA; Lanza GA; Crea F
    Int J Cardiol; 2017 Dec; 248():14-19. PubMed ID: 28807510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary plaque characteristics that indicate distal embolization during percutaneous coronary intervention in patients with stable angina-virtual histology intravascular ultrasound study.
    Inoue F; Ueshima K; Fujimoto T; An K; Uemura S; Saito Y
    Cardiovasc Interv Ther; 2013 Jul; 28(3):227-34. PubMed ID: 23381575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Having the COURAGE to include PCI in shared decision-making for stable angina.
    Khot UN
    Cleve Clin J Med; 2018 Feb; 85(2):124-127. PubMed ID: 29425083
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Zhao K; Li Y; Gao Q
    Int J Cardiol; 2015 Oct; 197():276-8. PubMed ID: 26142973
    [No Abstract]   [Full Text] [Related]  

  • 39. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.
    Wolfram RM; Torguson RL; Hassani SE; Xue Z; Gevorkian N; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Apr; 97(7):984-9. PubMed ID: 16563901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
    Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.